Claris Lifesciences has received USFDA approval for generic Flumazenil injection used for reversal of the sedative effects of benzodiazepines in the United States. The company has received drug approval Flumazenil injection USP 0.5 mg/5mL and 1 mg/10 mL multiple dose vials.
Company Profile : Claris Lifesciences Ltd
Leave a Reply